Literature DB >> 23500074

First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection.

Samar N El-Beshbishi1, Amira Taman, Mohamed El-Malky, Manar S Azab, Amira K El-Hawary, Dina A El-Tantawy.   

Abstract

Praziquantel is the current drug of choice against schistosomiasis. The dependency on praziquantel exclusively is problematic, given the spread of the disease and the threat of drug resistance. This study investigates an alternative antischistosomal drug using the compound naphthoquine phosphate tablet, which is a novel single oral dose antimalarial drug, containing a combination of naphthoquine phosphate and artemisinin. In the present study, the therapeutic efficacies of different artemisinin-naphthoquine phosphate combination-dosing protocols were evaluated in experimentally infected mice harbouring juvenile or adult stages of Schistosoma mansoni (Egyptian strain). The study shows that the oral administration of artemisinin-naphthoquine phosphate combination in a single dose of 400 mg/kg on day 7 p.i. resulted in a significant worm burden reduction of 95.07%. When used at a dose of 600 mg/kg on day 21 p.i., all female worms were killed before depositing eggs, resulting in complete absence of eggs in hepatic and intestinal tissues. The same dose given on day 42 p.i. reduced total and female worm burdens by 93.36% and 94.17%, respectively. In addition, artemisinin-naphthoquine phosphate combination induced significant reductions of 80.18% and 76.73% in the hepatic and intestinal tissue egg loads, respectively. Artemisinin-naphthoquine phosphate combination also induced significant alterations in the oogram pattern with elevated levels of dead eggs. Antipathological activities were evident in the amelioration of hepatic granulomata. Our findings hold promise for the development of a novel antischistosomal drug using an artemisinin-naphthoquine phosphate combination. Further in vitro and in vivo studies should be launched to elucidate the possible mechanism/s of action and to study the effect of artemisinin-naphthoquine phosphate combination on other human schistosomes.
Copyright © 2013 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500074     DOI: 10.1016/j.ijpara.2013.01.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  10 in total

1.  Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.

Authors:  Serry A El Bialy; Amira Taman; Samar N El-Beshbishi; Basem Mansour; Mohamed El-Malky; Waleed A Bayoumi; Hassan M Essa
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

2.  Effect of phenyl vinyl sulphone cysteine protease inhibitor on Schistosoma mansoni: in vitro and in vivo experimental studies.

Authors:  Manal Salah El-Din Mahmoud; Ayman Nabil Ibrahim; Abeer Fathy Badawy; Nourhan Mohamed Abdelmoniem
Journal:  J Parasit Dis       Date:  2017-06-22

Review 3.  Present-day anthelmintics and perspectives on future new targets.

Authors:  Amira Taman; Manar Azab
Journal:  Parasitol Res       Date:  2014-06-04       Impact factor: 2.289

4.  Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.

Authors:  Gihan Mostafa Tawfeek; Mohammad Hassan Abdel Baki; Ayman Nabil Ibrahim; Marmar Ahmad Hanafy Mostafa; Mohamed Mahmoud Fathy; Marwa Salah El Din Mohamed Diab
Journal:  Parasitol Res       Date:  2019-10-31       Impact factor: 2.289

Review 5.  Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

Authors:  Brioni R Moore; Moses Laman; Sam Salman; Kevin T Batty; Madhu Page-Sharp; Francis Hombhanje; Laurens Manning; Timothy M E Davis
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

6.  A penta-substituted pyridine alkaloid from the rhizome of Jatropha elliptica (Pohl) Muell. Arg. is active against Schistosoma mansoni and Biomphalaria glabrata.

Authors:  Aldenir Feitosa dos Santos; Saskya Araújo Fonseca; Fernanda Andrade César; Mônica Camelo Pessoa de Azevedo Albuquerque; José Valfrido Santana; Antônio Euzébio Goulart Santana
Journal:  Parasitol Res       Date:  2014-02-06       Impact factor: 2.289

Review 7.  Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.

Authors:  Maria João Gouveia; Paul J Brindley; Fátima Gärtner; José M Correia da Costa; Nuno Vale
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-05

8.  Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni.

Authors:  Laila Abdel Moniem Hegazy; Mona Hussein Al Motiam; Naglaa Fathy Abd El-Aal; Shereen Mahmoud Ibrahim; Heba Khalil Mohamed
Journal:  Iran J Parasitol       Date:  2018 Apr-Jun       Impact factor: 1.012

Review 9.  Control Strategies for Carcinogenic-Associated Helminthiases: An Integrated Overview.

Authors:  José Manuel Correia da Costa; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Júlio Santos; Lúcio Lara Santos
Journal:  Front Cell Infect Microbiol       Date:  2021-03-24       Impact factor: 6.073

10.  Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo.

Authors:  Shengwei Ji; Mingming Liu; Eloiza May Galon; Mohamed Abdo Rizk; Bumduuren Tuvshintulga; Jixu Li; Iqra Zafar; Yae Hasegawa; Aiko Iguchi; Naoaki Yokoyama; Xuenan Xuan
Journal:  Parasit Vectors       Date:  2022-01-07       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.